Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Patient satisfaction and physician productivity in shared medical appointments for vitiligo.

Tkachenko E, Refat MA, Balzano T, Maloney ME, Harris JE.

J Am Acad Dermatol. 2019 Mar 22. pii: S0190-9622(19)30462-1. doi: 10.1016/j.jaad.2019.03.044. [Epub ahead of print]

PMID:
30910662
2.

Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo.

Richmond JM, Strassner JP, Zapata L Jr, Garg M, Riding RL, Refat MA, Fan X, Azzolino V, Tovar-Garza A, Tsurushita N, Pandya AG, Tso JY, Harris JE.

Sci Transl Med. 2018 Jul 18;10(450). pii: eaam7710. doi: 10.1126/scitranslmed.aam7710.

PMID:
30021889
3.

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure.

Liu LY, Strassner JP, Refat MA, Harris JE, King BA.

J Am Acad Dermatol. 2017 Oct;77(4):675-682.e1. doi: 10.1016/j.jaad.2017.05.043. Epub 2017 Aug 18.

Supplemental Content

Loading ...
Support Center